Pritzker investing in materials firm Vertellus
Print
Investment firm Pritzker Private Capital has acquired a stake in materials firm Vertellus for an undisclosed price.
Chicago-based PPC is investing in Vertellus along with President and CEO John Van Hulle and other members of the management team of the Indianapolis-based company, officials said in a Jan. 5 news release. Van Hulle and existing management will continue to lead the business. Vertellus is a leading specialty chemicals manufacturer with strong growth prospects and a compelling market opportunity, PPC Principal Thomas Chadwick said in the release. The company plays an important role in the development and production of in-demand consumer and industrial products, and we look forward to supporting Vertellus on its continued expansion and innovation excellence.
Newswire & Press Release / ProAmpac Debuts Recyclable Paper-Touch Flexible Packaging - Packaging Equipment / Service - AMPAC Holdings, LLC | ProAmpac newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 07, 2020
NEWTON, Mass., Dec. 7, 2020 /PRNewswire/ Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced the appointment of Alan Muney, MD to its Board of Directors. Dr. Muney is currently a senior healthcare advisor for Pritzker Private Capital, Arsenal Capital, Bain Management Consulting, and NEA Venture Capital. I feel privileged to be involved with such a talented team dedicated to the mission of bringing a great technology to market to help chronically ill patients, said Dr. Muney.
Previously Dr. Muney served as Cigna s Chief Medical Officer and Executive Vice President of Total Health and Network. In his role as Chief Medical Officer, Dr. Muney was responsible for Cigna s clinical strategy and policy, health advocacy programs, coverage policy, and quality measurement and improvement. As lead for Total Health and Network, Dr. Muney was responsible for